Terpenoid content of Valeriana wallichii extracts and antidepressant-like response profiles-Reference-Cited by-同舟云学术

Terpenoid content of Valeriana wallichii extracts and antidepressant-like response profiles

Published:2009-11-26 Issue:5 Volume:24 Page:686-691
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytother. Res.

Author:

Subhan Fazal,Karim Nasiara,Gilani Anwarul Hassan,Sewell Robert D. E.

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ptr.2980/fullpdf

Reference33 articles.

1. Initial exploratory observational pharmacology of Valeriana wallichii on stress management: a clinical report;Bhattacharyya;Nepal Medical College Journal,2007

2. Cytotoxic potential of valeriana constituents, and valerian tinctures;Bos;Phytomedicine,1998

3. Composition of the essential oil from roots and rhizomes of Valeriana wallichii DC;Bos;Flavour Fragrance J,1997

4. In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain;Cavadas;Arzneimittelforschung,1995

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Valeriana jatamansi: Bioactive Compounds and their Medicinal Uses;Current Topics in Medicinal Chemistry;2024-04

2. Antidepressant plants and their use by the Chiru tribes of Manipur, India;Exploratory Animal and Medical Research;2023-09-01

3. Biological Evaluation of Valeriana Extracts from Argentina with Potent Cholinesterase Inhibition for the Treatment of Neurodegenerative Disorders and Their Comorbidities—The Case of Valeriana carnosa Sm. (Caprifoliaceae) Studied in Mice;Pharmaceuticals;2023-01-16

4. Herbal Approaches in the Management of Mental Depression;CNS & Neurological Disorders - Drug Targets;2023-01

5. New Trends from Plant Secondary Metabolism in the Pharmaceutical Industry;Natural Secondary Metabolites;2023